In this free webinar, learn about the control of osmolality throughout the viral vector workflow and what this may mean for future process improvement within the field. The featured speaker will discuss how modulating osmolality in the early stages of AAV1 (Adeno-Associated Virus Serotype 1) upstream manufacturing can result in improved outcomes such as overall yield, quality, reduced manufacturing costs and improved efficiencies.
(PRWeb June 13, 2022)
Read the full story at https://www.prweb.com/releases/examining_the_use_of_osmolality_within_viral_vector_manufacturing_upcoming_webinar_hosted_by_xtalks/prweb18732051.htm
For more information, please visit
https://www.prweb.com/releases/examining[...]ed_by_xtalks/prweb18732051.htm